curcumin and didodecyldimethylammonium

curcumin has been researched along with didodecyldimethylammonium* in 1 studies

Other Studies

1 other study(ies) available for curcumin and didodecyldimethylammonium

Article	Year
Microfluidic fabrication of cationic curcumin nanoparticles as an anti-cancer agent. Nanoscale, 2012, Apr-21, Volume: 4, Issue:8 Curcumin nanoparticles of less than 50 nm in diameter are accessible using a continuous flow microfluidic rotating tube processor (RTP) under scalable conditions, at room temperature. A mixture of DDAB and Pluronic F127 renders higher stability of the curcumin nanoparticles in physiological pH 7.4 for up to eight hours. The nanoparticles have enhanced cytotoxicity in estrogens receptor negative and positive breast cancer cell lines compared with free curcumin. Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Curcumin; Drug Carriers; Female; Humans; Hydrogen-Ion Concentration; Microfluidic Analytical Techniques; Nanoparticles; Poloxamer; Quaternary Ammonium Compounds; Receptors, Estrogen	2012

Article

Year

Microfluidic fabrication of cationic curcumin nanoparticles as an anti-cancer agent.

Nanoscale, 2012, Apr-21, Volume: 4, Issue:8

Curcumin nanoparticles of less than 50 nm in diameter are accessible using a continuous flow microfluidic rotating tube processor (RTP) under scalable conditions, at room temperature. A mixture of DDAB and Pluronic F127 renders higher stability of the curcumin nanoparticles in physiological pH 7.4 for up to eight hours. The nanoparticles have enhanced cytotoxicity in estrogens receptor negative and positive breast cancer cell lines compared with free curcumin.

Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Curcumin; Drug Carriers; Female; Humans; Hydrogen-Ion Concentration; Microfluidic Analytical Techniques; Nanoparticles; Poloxamer; Quaternary Ammonium Compounds; Receptors, Estrogen

2012